Compare Ascendis Pharma A/S (ASND) vs Dow Inc (DOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Dow Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Dow Inc trades at $31.07 (market cap $22.58B). The key difference: Dow Inc is the larger of the two by market cap, and Dow Inc pays a 4.48% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | DOW | |
|---|---|---|
Market Cap | $16.67B | $22.58B |
Sector | Health | Basic Materials |
52-Week High | $277.18 | $41.87 |
52-Week Low | $189.74 | $20.65 |
Enterprise Value | $17.04B | $38.27B |
Dividend Yield | — | 4.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →
